According to the Atlanta Classification, acute pancreatitis is defined as an inflammatory process of the pancreas with variable involvement of regional tissues or remote organs 1 . The incidence of acute pancreatitis varies between five and 80 cases per 100,000 persons and is on the rise 2 . According to its severity, acute pancreatitis is designated mild or severe. Mild pancreatitis is linked with minimal organ dysfunction and a usually uneventful recovery 1 . Severe acute pancreatitis (SAP) is associated with organ failure, local complications, prolonged intensive care stay and mortality rates >25% 1 . In patients with SAP, the multiple organ dysfunction syndrome (MODS) is the main cause of death 3 . While in the early stage of the disease (<14 days), MODS is due mostly to overwhelming systemic inflammation while the majority of late deaths arise from MODS secondary to pancreatic or nosocomial infection.
This review gives an overview of the aetiology, pathophysiology, diagnosis and therapy of adult patients with acute pancreatitis relevant to the critical care clinician. In addition, recommendations on the management of acute pancreatitis are summarised and discussed.
METHODS
Using the PubMed database (search terms "acute pancreatitis" together with "critical care", "complications", "death", "aetiology/etiology", "pathophysiology", "diagnosis", "severity assessment", "laboratory investigation", "scoring systems", "radiology", "therapy", "nutrition", "necrosis", "antibiotic prophylaxis", "surgery" and "long-term outcome") and contemporary textbooks, a comprehensive literature review was performed that focused on clinical trials performed in adult patients with acute pancreatitis and on review articles in English or German language. Furthermore, the reference lists of selected manuscripts and book chapters were manually screened. The latest guidelines (published after 2000) [4] [5] [6] [7] [8] [9] were reviewed and summary statements established for key clinical, diagnostic and therapeutic questions. Wherever the current scientific evidence is still contradictory and does not fully support recommendations, this was mentioned following the summary statements.
Aetiology
In industrialised nations, 80% of acute pancreatitis cases are caused by alcohol abuse or gallstones 10 . Although 35 to 40% of attacks are induced by gallstones, only 3 to 7% of patients with gallstones develop pancreatitis 11 . The incidence of gallstone pancreatitis is increased in white females >60 years and is highest among patients with small gallstones (<5 mm diameter) 2 . These and other less frequent causes of acute pancreatitis are summarised in Table 1 . Together with alcohol abuse the most frequent cause of acute pancreatitis in Western countries, female predominance.
Alcohol abuse Most frequently observed in males aged 30 to 45 years; often associated with alcoholic hyperlipidaemia and cigarette smoking, which together with alcohol might have an additive effect in inducing pancreatitis.
Endoscopic retrograde cholangiopancreatography (ERCP)
Mild pancreatitis occurs in 3 to 5% of all ERCP patients and in up to 25% of patients undergoing sphincter of Oddi manometric studies; ~1% of patients develop severe course of pancreatitis. Chemoprevention of post-ERCP pancreatitis has been achieved with gabexate, ulinastatin, indomethacin or octreotide.
Abdominal trauma Most frequent cause of pancreatitis in children (e.g. bicycle accidents), caused by laceration of the pancreatic duct.
Surgical trauma
Rare and severe complication after cardiac surgery and massive bleeding with hypovolaemia and shock due to vasospasm (renin-angiotensin) and microcirculatory dysfunction.
Metabolic causes Hyperlipoproteinaemia (types I, III, V): pancreatitis occurs frequently in combination with alcohol abuse, triglyceride levels usually exceed 1000 mg/dl altering pancreatic microcirculation (hyperviscosity syndrome); uraemia, hypercalcaemia (calcium deposits in the pancreatic duct and trypsin activated in the acinar cells) and hypothermia are rare causes of pancreatitis.
Infections
Pancreatitis accompanying viral infections (mumps, hepatitis B, cytomegaly, varicella zoster, herpes simplex, echo and coxsackie virus) is usually mild and self-limited. Bacterias that have been associated with pancreatitis are mycoplasma, legionella, campylobacter jejuni or coli, or salmonella spp.
Drugs
More than 80 drugs can provoke pancreatitis; most drug reactions are idiosyncratic. According to the number of cases reported, drugs are grouped in classes I to III: Class I (>20 published reports): didanosine, asparaginase, azathioprine, valproic acid, pentamidine, mercaptopurine, oestrogen, opiates, tetracycline, steroids, trimethoprim, sulfadiazine, furosemide; Class II (>10 published reports): rifampin, lamivudine, octreotide, carbamazepine, acetaminophen, phenformin, interferon α2b, enalapril, hydrochlorthiazide, cisplatin, erythromycin, cyclopenthiazide; Class III (all medications reported to be associated with pancreatitis).
Vascular and autoimmune causes
Panarteritis nodosa, systemic lupus erythematodes, thrombotic thrombocytopenic purpura.
Mechanical causes other than gallstones
(Peri)pancreatic tumours, duodenal diverticula, papillary stenosis (e.g. due to celiac disease), pancreas divisum (7% of autopsies), penetrating duodenal ulcer, gastric resection, gastrojejunostomy with afferent loop syndrome, pancreas carcinoma, parasitic infection (e.g. Ascaris lumbricoides, Clonorchis sinesis).
Toxic causes
Intoxication with methanol, cobalt, zinc, mercury, cadmium or organophosphate; scorpion venom (Trinidad).
Autoimmune causes Mostly mild forms, has been associated with Sjögren's disease, primary sclerosing cholangitis, primary biliary cirrhosis, retroperitoneal fibrosis, rheumatoid arthritis, and sarcoidosis; diagnosis is confirmed by serum IgG4 levels and pancreatic biopsy; usually good treatment response to steroids.
Miscellaneous causes
Pregnancy, acute or chronic rejection after pancreas transplantation, renal transplantation, alpha 1 -antitrypsin deficiency.
Hereditary causes Onset often in childhood, tends to become chronic.
Idiopathic or unexplained causes
In up to 5% of patients with acute pancreatitis no cause can be determined.
Guidelines summary statement: aetiology
The aetiology of acute pancreatitis should be determined in at least 75 to 80% of acute pancreatitis patients 4, 6 .
Pathophysiology
The pathophysiology of acute pancreatitis can be grouped into three phases 5 . The first phase is characterised by the premature activation of trypsin in acinar cells. The second phase is the inflammatory response of the pancreas, which is disproportionate to the response of other organs to a similar insult. In the third phase, systemic activation of the immune system and remote organ dysfunctions occur.
Of all causes, the pathophysiology of biliary pancreatitis has been investigated most. In contrast to earlier beliefs that reflux of bile into the pancreatic duct induced pancreatitis
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, the main cause of biliary pancreatitis is impaired drainage of pancreatic juice because of continuous or temporary obstruction of the common bile duct 13 . Elevated intraductal pressures alter the membrane potential of acinar cells and increase intracellular calcium levels 14 . Pancreatitis due to other causes of ampullary obstruction follows a similar pathophysiologic pattern. Despite its important aetiologic role, the pathophysiology of alcoholic pancreatitis is not fully understood. One hypothesis is that ethanol sensitises acinar cells to cholecystokinin and potentiates its effects on the activation of transcription factors such as nuclear factor κB and activating protein-1. Certain patterns of alcohol intake may further influence the pancreatic inflammatory response 15 . Additional potential mechanisms include toxic effects of acetaldehyde on acinar cells, induction of microtubular dysfunction and oxidative stress, as well as uncoupling of mitochondrial oxidative phosphorylation 16 . The prediction of severe disease, before its onset, is best achieved by careful ongoing clinical assessment coupled with the use of a • multiple-factor scoring system and imaging studies. The APACHE II system is preferred, with a cut-off of ≥8. Those with predicted or actual severe disease, and those with other severe comorbid medical conditions, should be strongly considered for triage to an ICU or intermediate medical care unit.
Laboratory tests may be used as an adjunct to clinical judgement, multiple-factor scoring systems, and CT to guide clinical triage deci-• sions. A serum C-reactive protein level >150 mg/l at 48 hours after disease onset is preferred.
United Kingdom Working Party on Acute Pancreatitis 2005

6
• Available prognostic features that predict complications in acute pancreatitis are clinical impression of severity, obesity, or APACHE II ≥8 in the first 24 hours of admission, and C-reactive protein >150 mg/l, Glasgow score 3 or more, or persisting organ failure after 48 hours in hospital (recommendation grade B).
Japanese Guidelines for the Management of Acute Pancreatitis 2006
9 Assessment with a severity scoring system (JPn score, APACHE II score) is important for determining treatment policy and identifying • the need for transfer to a specialist unit.
C-reactive protein is a useful indicator for assessing severity. • Contrast-enhanced computed tomography scanning and contrast-enhanced magnetic resonance imaging play an important role in • severity assessment.
A JPn score of 2 or more has been established as the criterion for hospital transfer. •
Guidelines of the Committee of the American College of Gastroenterology 2006
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Older age (>55), obesity (BMI >30), organ failure at admission, and pleural effusion and/or infiltrates are risk factors for severity • that should be noted at admission. Patients with these characteristics may require treatment in a highly supervised area, such as a step-down unit or an ICU.
The two tests that are most helpful in distinguishing mild from severe acute pancreatitis at admission are the APACHE II score and • serum haematocrit. It is recommended that APACHE II scores be generated during the first three days of hospitalisation and thereafter as needed to help this distinction. It is also recommended that serum haematocrit be obtained at admission, 12 hours after admission, and 24 hours after admission to help gauge adequacy of fluid resuscitation.
Consensus Conference of Critical Care Clinicians 2004
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[…]. Disease-specific scoring systems and global illness severity scores may be useful adjuncts for identifying patients at high risk for • complications; however, these models are no substitute for frequent serial clinical assessments.
We recommend against the routine use of markers such as C-reactive protein or procalcitonin to guide clinical decision making, predict • the clinical course of pancreatitis, or to triage patients.
JPn=Japanese, APACHE=Acute Pathology and Chronic Health Evaluation, ICU=intensive care unit, CT=computed tomography, BMI=body mass index.
Irrespective of its cause, the final pathway of acute pancreatitis is the premature and unregulated activation of trypsin in acinar cells 17, 18 . Increased calcium levels and disruption of calcium signalling in acinar cells are considered prerequisites for trypsin activation. As a result, intracellular protective mechanisms (e.g. pancreatic secretory trypsin inhibitor, mesotrypsin, enzyme y, alpha 1 -antitrypsin, alpha 2 -macroglobulin) are overwhelmed. Once trypsin is activated, other pancreatic enzymes such as phospholipase A 2 , chymotrypsin, elastase, histamine, the complement cascade and kinin pathway become activated 17 .
Diagnosis and differential diagnosis
All guidelines agree that the diagnosis of acute pancreatitis should include at least two of the following features: 1) acute abdominal pain characteristic for pancreatitis, 2) elevated levels of serum amylase and/or lipase ≥3 times the upper normal limit, 3) characteristic findings on computed tomography scan or related radiographic techniques [4] [5] [6] 9 . The most important differential diagnoses are mesenteric ischaemia, perforated gastric/duodenal ulcer, biliary colic, aortic dissection, intestinal obstruction and acute coronary syndromes 5 .
Assessment of disease severity
Predicting the course of pancreatitis preferentially within the first 24 hours and ideally at initial presentation could permit timely commencement of therapeutic interventions. The recommendations made by individual guidelines are summarised in Table 2 .
Clinical presentation
The leading symptom of acute pancreatitis is dull upper abdominal pain, which may be alleviated by postural changes. Pain is typically located in the epigastric or umbilical region and frequently radiates to the back. While pain in biliary pancreatitis often starts postprandially and in the right upper quadrant, acute pancreatitis related to alcohol mostly occurs one to three days after a binge or cessation of drinking
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. Painless pancreatitis is uncommon, but can be seen in the postoperative setting, in patients under peritoneal dialysis and those with legionella or leptospirosis infections 20, 21 . In 90% of patients, pain is of rapid onset and associated with nausea and vomiting. Fever is regularly observed. Early jaundice indicates cholangitis or pancreatic head oedema with bile flow obstruction 20, 22 . Gastrointestinal A distended abdomen without bowel sounds indicates intestinal paralysis with or without ascites. Palpation of a tumour can indicate a pseudocyst or abscess (in late disease stage). Acute jaundice suggests obstruction of the biliary tract Other causes may be oedema of the pancreatic head or pancreas tumour.
Cutaneous
Ecchymotic discolorations of the umbilical area (Cullen's Sign), flanks (Grey-Turner's Sign) or the groin (Fox Sign) are unspecific signs of retro-or intra-abdominal haemorrhage. In pancreatitis, they are associated with a mortality of >30%. Less common are subcutaneous fat necrosis (paniculitis, mostly 0.5 to 2 cm tender red nodules over distal extremities), thrombophlebitis and polyarthritis.
Haematologic Anaemia is common after adequate fluid resuscitation. Thrombopenia is typically seen in alcoholic patients and severe forms of pancreatitis. Mild plasmatic coagulation disorders are frequently observed. Disseminated intravascular coagulation is rare and occurs only in the most critically ill.
Metabolic
Respiratory acidosis and alkalosis depending on pulmonary function and presence of systemic inflammation; metabolic acidosis (often lactic acidosis), hypocalcaemia, hyperglycaemia, hypertriglyceridaemia (frequently in alcohol-associated pancreatitis).
Renal
Oliguria at presentation is almost always a sign of hypovolaemia; acute kidney injury can be the consequence of inadequate fluid resuscitation or severe systemic inflammation; renal artery thrombosis is a rare but grave complication.
Central nervous Often termed 'pancreatic encephalopathy'. When compared to acute delirium, as conventionally observed in critically ill patients, pancreatic encephalopathy may also be caused by circulating activated pancreatic enzymes, first of all phospholipase A2, which is known to damage the blood-brain barrier and induce demyelination and cerebral oedema. Differentially, consider alcohol withdrawal syndrome or any other neurologic syndrome associated with chronic alcohol abuse. Blindness is a rare feature of pancreatitis (Purtscher's retinopathy). 
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. The first attack of pancreatitis is 10 to 15 times more frequently associated with SAP and a high risk of death than is any recurrent attack 24 . Further clinical features of SAP are advanced age (>55 years), body mass index >30 kg/m² 25 , presence of comorbid illness and pleural effusion/infiltration 5 .
Laboratory investigations
While high serum amylase levels are frequently observed in patients with non-alcoholic pancreatitis, up to one-third of patients with alcohol-associated pancreatitis may have no or only moderate elevations in amylase levels (Table 4) 26 . Isoamlyase is more specific for acute pancreatitis than is total amylase 27 . In acute pancreatitis, amylase rises within six to 12 hours, is cleared rapidly from the circulation (half-life ~10 minutes) and returns to normal within three to five days 28 . Although lipase is more specific for pancreatitis than is amylase 29 , increased serum levels can also be found in many other conditions 30 . Lipase has a longer half-life than does amylase and remains elevated for one to two weeks 29 . This is why certain guidelines recommend determining lipase levels in acute pancreatitis patients with delayed presentation 6 . Although the serum amylase/lipase ratio has been used to distinguish between alcoholic and nonalcoholic pancreatitis 31 , routine combination of the two enzymes cannot improve diagnostic accuracy 32 . Similarly, since the level of pancreatic enzyme elevation is not associated with disease severity 33 , daily measurements have little value in assessing the disease course. However, when amylase and/or lipase levels remain elevated for weeks, persisting pancreatic inflammation, pancreatic duct obstruction or a pseudocyst should be suspected 34 . During the pancreatic inflammatory process, digestive enzymes other than amylase and lipase leak into the circulation. Increased levels of the trypsinogen activation peptide, trypsinogen 2 (urine and serum), or anionic trypsinogen 2 can be detected early in the course of pancreatitis 35, 36 . However, similar to amylase and lipase, their serum values do not correlate with disease severity 37 . Alpha 2 -macroglobulin is an non-specific protease inhibitor produced by the liver and consumed by pancreatic proteases. Levels <1.3 mg/dl indicate SAP with a high sensitivity and specificity 38 . C-reactive protein is synthesised in the liver and a serum concentration greater than 150 mg/l within the first 72 hours correlates with the presence of pancreatic necrosis (sensitivity and specificity >80%) 5 and is an independent predictor of mortality 28, 29 . Because C-reactive protein reaches its peak levels only 36 to 96 hours after disease onset, it is not helpful in assessing the severity of acute pancreatitis at initial presentation 5 . Another pitfall is that it can be falsely low in patients with chronic liver disease 39 . However, when measured daily, C-reactive protein is 28, 42 could be other valuable biochemical markers for assessing acute pancreatitis. Increases in lactate dehydrogenase and aspartate aminotransferase levels are non-specific signs of cell destruction and frequently seen in biliary pancreatitis (>80%) 43 . An elevated aspartate aminotransferase level in female patients with acute pancreatitis but no history of alcohol abuse is the single best predictor of biliary pancreatitis. Levels of three times or greater than the upper limit of normal have a positive predictive value of 95% for gallstone pancreatitis, but a sensitivity of only 48% 44 . Serum carbohydratedeficient transferrin can help distinguish alcoholic from non-alcoholic acute pancreatitis 45, 46 . At a cutoff value >17 IU/l, the specificity of carbohydratedeficient transferrin is 100% and its sensitivity 75% for detecting an alcoholic aetiology of acute pancreatitis
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.
Scoring systems
In patients with alcohol-induced pancreatitis, Ranson et al established 11 criteria that are evaluated at admission and after 48 hours and that can predict mortality 47 . If three or more criteria are met a complicated course with an increased risk of death must be anticipated. The principal disadvantage of applying these criteria is that their evaluation requires at least 48 hours, a time during which the diagnosis and severity assessment of acute pancreatitis should be completed [4] [5] [6] . Accordingly, a meta-analysis of 19 studies concluded that the Ranson criteria offer no advantage over clinical examination in predicting disease severity 48 . A recent multicentre study including 2462 acute pancreatitis patients introduced the Pancreatitis Outcome Prediction Score 49 . Variables with the highest sensitivity and specificity to predict death were arterial pH, age, blood urea nitrogen, mean arterial blood pressure, the partial arterial oxygen tension/inspiratory oxygen concentration ratio and serum potassium. The 'Panc 3' score focuses on three important clinical variables and can accurately predict SAP. The combination of haematocrit >44 mg/dl, a body mass index >30 kg/m² and pleural effusion in the chest X-ray on initial presentation has a >90% likelihood of predicting the development of SAP 50 . General scoring systems such as the Acute Physiology and Chronic Health Evaluation (APACHE) 51 , Simplified Acute Physiology Score 52 or the Sequential Organ Failure Assessment Score 53 may be just as good, if not better, in identifying patients with increased morbidity and mortality than are pancreatitis-specific scoring systems. For example, in patients with clinical and radiologic signs of pancreatitis, an APACHE II score greater than 8 indicates SAP [4] [5] [6] 54 .
Radiographic criteria
Radiographic techniques have become essential not only to diagnose pancreatitis, determine its aetiology and severity, but also to detect and treat associated complications. Contrast-enhanced computed tomography is considered the radiologic technique of choice [4] [5] [6] 8, 9 . Computed tomography findings indicating pancreatitis include diffuse enlargement of the gland, heterogeneity of the pancreatic parenchyma, peripancreatic stranding and peripancreatic fluid collections 5 . Although animal data suggest that ionic contrast worsens pancreatitis by increasing the extent of necrosis 55 , this was not observed in the clinical setting 56 . Radiocontrast allows identification of pancreatic necrosis that appears as focal (>3 cm) or diffuse areas of nonenhanced parenchyma (<50 Hounsfield units after intravenous contrast) 5 . Since pancreatic necrosis can develop until 72 to 96 hours after disease onset, computed-tomography studies to evaluate the extent of pancreatic involvement should either be delayed until or repeated 72 hours after initial presentation 4, 5, 8 . These contrast-enhanced computed-tomography findings correlate with the incidence of complications and mortality and were graded in a score (Table 5 , Figures 1 to 3) 57,58 . When contrast media are contraindicated and the patient is stable, pancreatic necrosis may be evaluated with high sensitivity using magnetic resonance tomography 59 . Magnetic resonance imaging can further distinguish pancreatic necrosis as seen on computed tomography into necrotic parenchyma, peripancreatic fluid collections and hemorrhagic foci 60 . Magnetic resonance cholangiopancreatography can help in diagnosing biliary pancreatitis 61 . Ultrasonography is primarily used to detect gallstones (sensitivity 60 to 70%) or pseudocysts. In 25 to 75% of patients, however, bowel gas obscures the pancreas and prevents parenchymal changes (diffusely enlarged hypoechoic pancreas) or concrements of the common bile duct from being visualised 62 . Endoscopic ultrasonography may be used as an accurate means of screening for gallstones and indicating endoscopic interventions 63 . An abdominal X-ray can be helpful if computed tomography is not readily available. A localised, paralytic intestinal loop ('sentinel loop'), paucity of air in the colon distal to 57, 58 CT grade Appearance on CT Points 0 to 1 point=0% complications, 0% mortality, 2 to 3 points=8% complications, 3% mortality, 4 to 6 points=35% complications, 6% mortality, 7 to 10 points=32% complications, 17% mortality.
figure 1: Graduation of the severity of acute pancreatitis based on contrast-enhanced computed tomography 57, 58 : Grades A and B. Grade A=normal pancreas, Grade B=enlargement of the pancreas with loss of lobular structure.
figure 2: Graduation of the severity of acute pancreatitis based on contrast-enhanced computed tomography 57, 58 : Grades C and D. Grade C=Grade B plus mild peri-pancreatic inflammation, Grade D=Grade C plus considerable peri-pancreatic inflammation with paracolic fluid collections.
figure 3: Graduation of the severity of acute pancreatitis based on contrast-enhanced computed tomography 57, 58 : Grade E. Grade E=the pancreatic parenchyma does not accumulate contrast-reflecting complete necrosis of the pancreas, massive peri-pancreatic exudation or a filiform superior mesenteric vein (arrow). the splenic flexure due to functional spasm of the descending colon ('colon cut-off sign'), pancreatic calcifications as seen in chronic pancreatitis, blurred margins of the psoas muscles or calcified biliary concrements can be indirect signs of pancreatitis. Generalised ileus is often seen in severe disease; a ground glass appearance indicates ascites 64 .
Therapy
Many patients with SAP develop complications and require prolonged intensive care. To guarantee optimum management, most guidelines recommend the close co-operation of an experienced multidisciplinary team consisting of intensivists, (interventional) radiologists, surgeons and gastroenterologists 6, 8 . Implementation of a specialised treatment protocol can reduce complications and improve outcome 65 .
Causative therapy
Unfortunately, only few patients with acute pancreatitis are amenable to causative treatments. nonetheless, each patient, particularly those with SAP, must be evaluated to determine if the underlying cause can be eliminated.
Endoscopic retrograde cholangiopancreatography
There is general consensus that patients with biliary pancreatitis and obstructive jaundice should undergo endoscopic retrograde cholangiopancreatography (ERCP) 66 . If gallstones or concrements are identified, endoscopic sphincterotomy is recommended 66 . Percutaneous transhepatic gallbladder drainage may be a reasonable alternative technique if ERCP is not possible 67 . However, in most patients with biliary pancreatitis bile duct obstruction is only transient and jaundice is not present 13 . In these patients, the role of urgent ERCP is less clear. Various studies, including a recent randomised trial 68 , have rendered controversial results. While earlier meta-analyses suggested beneficial effects of early ERCP in patients with suspected biliary pancreatitis 69 , the latest meta-analysis could not detect such an advantageous effect 70 .
Further causative therapies Cessation and avoidance of drugs with potential pancreas toxicity is a logical step in patients with or without suspected drug-induced pancreatitis 71 .
In patients with hypercalcaemic pancreatitis, temporary or definite therapies to lower calcium levels such as forced diuresis, haemodialysis, biphosphonate therapy, steroids (e.g. vitamin D intoxication, sarcoidosis, plasmocytoma) or partial/ total parathyreoidectomy should be initiated 72 . Diet, insulin, heparin, lipid-decreasing drugs and plasma exchange may be indicated in patients with pancreatitis due to hyperlipidaemia 73 . Prednisone 0.5 to 1 mg/kg can dramatically improve autoimmune pancreatitis 74 .
Supportive therapy Haemodynamic resuscitation
Cardiovascular and microcirculatory failure is the main determinant of outcome during the early stage of SAP 3, 75, 76 . Early fluid resuscitation and adequate oxygen delivery can prevent or minimise pancreatic necrosis 77 . However, at first presentation, the extent of hypovolaemia in these patients is almost always underestimated 78 . Monitoring of the cardiovascular system should be directed toward the repeated assessment of intravascular volume status by means of physical examination and monitoring of urine output 8 . In addition to hypovolaemia, the cardiovascular system of SAP patients can further be impaired by a variable degree of systemic vasodilatation and myocardial dysfunction 79 .
Respiratory therapy
Two peaks of pulmonary complications are observed during early acute pancreatitis. The first peak occurs at admission when radiographic signs of lung injury are seen in 15% of patients. By day five, new radiographic abnormalities develop in up to 70% of patients 80 . Acute lung injury in early pancreatitis is caused by inflammatory changes with leukocyte Guidelines summary statement: supportive therapy All guidelines agree that close clinical monitoring combined with vigorous fluid resuscitation and supplemental oxygen is the mainstay of supportive therapy in acute pancreatitis [4] [5] [6] 8, 9 .
Guidelines summary statement: ERCP in acute pancreatitis
There is consensus among all guidelines that ERCP should be performed within 24 to 72 hours after onset of pain in acute pancreatitis patients with cholangitis of proven or strongly suspected gallstone aetiology [4] [5] [6] 8, 9 . While most guidelines consider it reasonable to also perform endoscopic sphincterotomy in the absence of gallstones, the United Kingdom Working Party on Acute Pancreatitis recommends performing sphincterotomy in all acute pancreatitis patients undergoing ERCP, irrespective of the presence of gallstones 6 .
Conflicting evidence:
While there is reliable evidence supporting ERCP in patients with cholangitis and acute pancreatitis, data on the usefulness of ERCP in patients with transient obstruction of the common bile duct is conflicting. Larger trials are needed to investigate the role of routine ERCP with or without sphincterotomy in patients with biliary pancreatitis but no ongoing bile flow obstruction.
plugging of capillaries, formation of pulmonary oedema and atelectasis, as well as reduced chest wall compliance due to increased intra-abdominal pressure 81 . These patients usually present with respiratory distress, tachycardia, diaphoresis and anxiety. The chest X-ray frequently demonstrates left-sided or bilateral pleural effusions, elevation of the diaphragm, basal atelectasis and pulmonary oedema 80 . If mechanical ventilation is delayed, hypoxaemia can aggravate tissue damage and MODS. Mechanical ventilation should be applied using lung-protective ventilation strategies such as adequate positive end-expiratory pressures, tidal volumes of 6 ml/kg ideal body weight and permissive hypercapnia 8 . Spontaneous breathing must be encouraged as early as possible. Lung complications during later stages of SAP are mainly associated with pulmonary or extra-pulmonary infections 82 .
Intra-abdominal hypertension
An observational study of 293 SAP patients demonstrated that early organ dysfunction (<72 hours after presentation) was associated with intra-abdominal hypertension grade II (16 to 20 mmHg) or higher in 78% of patients 83 . Massive oedema of abdominal organs with ascites formation and distension of intestinal loops can increase intra-abdominal pressure and result in vascular compression, reduced venous return, decreased cardiac output, increased arteriolar resistance, impaired organ blood flow and MODS. Moreover, tissue hypoxia is aggravated by arterial hypoxaemia resulting from impaired respiratory mechanics 84 . The abdominal compartment syndrome is defined as an intra-abdominal pressure >20 mmHg with evidence of organ dysfunction/failure 85 . Aside from progressive abdominal distension, oliguria and increased biventricular filling pressures are frequently the first clinical symptoms of intra-abdominal hypertension 86 . Intra-abdominal pressures may be conservatively decreased by gastric decompression, postural changes, sedation, neuromuscular relaxation and, if clinically applicable, negative fluid balance. However, when MODS progresses and/or abdominal compartment syndrome develops, urgent surgical intervention is required 87 .
nutrition
While putting the intestinal tract at rest until abdominal pain has subsided is a clinically practicable method in patients with mild pancreatitis 88 , recent data show that such a strategy can be harmful in SAP. Compelling evidence indicates that early enteral nutrition (within 72 hours) in SAP is safe and reduces infectious complications 19, [89] [90] [91] . A major benefit of enteral nutrition is its ability to maintain the integrity of the intestinal barrier and avoid total parenteral nutrition, which is associated with a pro-inflammatory response 19, 91 . There are few relative and even fewer absolute contraindications for enteral nutrition in SAP patients. Abdominal compartment syndrome is generally considered an absolute contraindication until surgical decompression is achieved 87 . Although patients with paralytic ileus have been enterally fed 92 , (jejunal) tube feeding into an atonic bowel can cause the intraluminal pressure to exceed the mucosal perfusion pressure and induce intestinal ischaemia 93 . Patients with severe shock may be at particular risk of having paralytic ileus and compromised mucosal perfusion. Despite the high expectations set in the use of probiotics to reduce small-bowel bacterial overgrowth 94, 95 , probiotic prophylaxis did not reduce the risk of infectious complications in SAP patients in a recent multicenter trial 96 . On the contrary, patients receiving probiotics exhibited a higher incidence of bowel ischaemia than did controls (9% vs. 0%, P=0.004). Immunonutrition in SAP patients resulted in higher C-reactive protein levels compared to isonitrogenous feed 97 . Experimental and physiologic studies have shown that delivery of nutrients proximal to the ligament of Treitz released cholecystokinin and thus stimulated pancreas secretion 98 . Although no study has been conducted in patients with acute pancreatitis where pancreatic exocrine secretion in response to cholecystokinin is markedly suppressed 99 , most clinicians prefer the jejunal route. There is growing evidence that nasogastric tube feeding in SAP patients may be simpler and share a similar safety Guidelines summary statement: nutrition All guidelines prefer the enteral over the parenteral route for nutritional support [4] [5] [6] 8, 9 . Pareneteral nutrition is considered indicated when no nutrition can be provided for more than seven days. There is debate on the enteral route of choice. While two guidelines suggest nasojejunal feeding 4, 8 , the United Kingdom Working Party on Acute Pancreatitis recommends the nasogastric route 6 . The consensus conference of critical care clinicians suggests supplementing parenteral nutrition with glutamine and recommends against the use of immuneenhancing enteral formulas 8 .
Conflicting evidence:
While the evidence for the benefits of enteral over parenteral nutrition is firm, there are still too few controlled data to favour either the nasogastric or the nasojejunal route.
Regarding the composition of enteral nutrition, the only safe conclusion is that preparations containing multispecies probiotics (including bifidobacteria) are not beneficial and are possibly even harmful in SAP.
profile. A recent meta-analysis of three randomised controlled trials found no differences in mortality or other outcome variables between the nasogastric and the nasojejunal route 100 . Two prospective studies published after this meta-analysis supported these conclusions 101, 102 .
Other supportive measures
Pain therapy: Although analgesics are important to relieve pain and attenuate neuroendocrine stress, their use in SAP has traditionally been debated because of experimental findings that morphine can induce spasm of the sphincter of Oddi and may precipitate pancreatitis. A consistent review of the literature revealed that all opiates increase sphincter of Oddi persistalsis and biliary pressure. no evidence exists to support the preference for any one opiate in pancreatitis patients 103 .
Strict glycaemic control:
In a multicentre trial, strict glycaemic control (target blood sugar levels 80 to 110 mg/dl) improved morbidity and mortality in surgical critically ill patients 104 . Advantageous effects of normoglycaemia were first attributed to the improvement of immunologic function and reduction of free radical production 105 . Recent evidence shows that insulin itself exerts potent anti-inflammatory effects, mostly by decreasing free fatty acids levels. Furthermore, insulin has antithrombotic effects and stimulates the endothelial nitric oxide synthase 106 . Since endothelial nitric oxide plays an important role in maintaining myocardial function, insulin may have cardioprotective properties also 107 .
Stress ulcer prophylaxis:
Because no clinical evidence exists on the effects of stress ulcer prophylaxis in acute pancreatitis patients, it seems wise to adopt the recommendations of the Surviving Sepsis Campaign 108 . In patients with severe sepsis or septic shock, stress ulcer prophylaxis using H 2 blockers or proton pump inhibitors is recommended to prevent upper gastrointestinal haemorrhage. In acute pancreatitis, this would mean that patients with signs of systemic inflammation and one or more organ dysfunctions should receive stress ulcer prophylaxis. In all cases, particularly in patients with mild acute pancreatitis, the benefit of preventing stress ulceration must be critically weighed against the potential risk of nosocomial pneumonia 109 .
Antithrombotic prophylaxis:
In accordance with guidelines included in the Surviving Sepsis Campaign 108 , antithrombotic prophylaxis should be instituted in critically ill patients with acute pancreatitis. Unfractionated or low molecular weight heparins reduce the incidence of deep vein thrombosis with pulmonary embolism and may prevent portal vein thrombosis. In patients with coagulopathy or a high risk of bleeding (e.g. into pancreatic necrosis), mechanical techniques (e.g. antithrombotic stockings, intermittent pneumatic compression) can be used to avert deep vein thrombosis 110 .
Therapies targeting the inflammatory response:
Since it is widely accepted that MODS associated with SAP originates from an uncontrolled inflammatory response, several experimental and clinical studies evaluated the role of therapies targeting pro-inflammatory mediators. Although most strategies were associated with beneficial effects in animal experiments, none could improve outcome in a major clinical trial. Therefore, most guidelines recommend against the use of immunemodulating therapies in SAP, such as anti-TnFα therapy 111 , gabexate mesilate 112 , lexipafant 113 or activated protein C
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. Although high-dose selenium therapy showed promising results in critically ill patients with sepsis and systemic inflammation 115 , a small prospective study found that the combination of n-acetylcysteine, selenium and vitamin C had no beneficial influence on the course of SAP 116 .
Antisecretory therapies: no treatment aiming to reduce pancreatic secretions such as cimetidine, atropine, calcitonin, glucagon, fluorouracil, somatostatin or octreotide favourably influenced the course of acute pancreatitis 117 .
Miscellaneous: Data from China suggest a potential role of (electro)acupuncture in improving gastrointestinal dynamics and mucosal integrity in acute pancreatitis patients 118, 119 .
Local complications of acute pancreatitis and their management
The definition and treatment of local complications of acute pancreatitis as suggested by the Atlanta Conference are summarised in Table 6 . Further complications are intestinal obstruction, inflammation, ischaemia or necrosis, splenic infarction, renal artery thrombosis and portal or splenic vein thrombosis 120 .
Infection of pancreatic necrosis
Infectious complications are the main causes of morbidity and mortality of SAP patients in the later stage of the disease 3 . In SAP, the rate of pancreatic necrosis infection is 30 to 50% and correlates with both the extent of necrosis and the duration of pancreatitis
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. Although its peak incidence usually occurs in the third week 121 , infection of the necrotic pancreas may occur as early as the first week. Pathophysiologic mechanisms are unclear but most likely involve haematogenous seeding, ascending infections of the biliary tree and translocation of bacteria from the gastrointestinal tract, first of all the colon 122 . The growing practice of antibiotic prophylaxis has lately been associated with a change in pancreatic isolates from gut-derived gramnegative bacteria to fungi and gram-positive organisms 123, 124 .
Antibiotic prophylaxis
The above-mentioned data combined with the adverse outcome associated with pancreatic necrosis infection prompted several investigations as to whether the prophylactic intravenous or oral administration of antimicrobials can reduce the rate of pancreatic necrosis infection. Table 7 displays the individual penetration rates of various antibiotics into pancreatic tissue. Despite promising results, the current scientific evidence does not support the routine use of prophylactic systemic antibacterial or antifungal agents in SAP patients. The latest meta-analysis observed a reduction in the length of hospital stay in SAP patients receiving prophylactic antibiotics, but could not detect any effect on the Pancreatic fistula* Abnormal connection between the pancreas and the adjacent organs (internal) or the skin (external).
Internal fistulae are often observed in alcohol-associated pancreatitis; external fistulae usually originate from iatrogenic causes (e.g. drainage or surgical debridement).
Spontaneous resolution within 4 to 6 weeks in 70 to 80% with a conservative approach (antibiotic coverage, correction of electrolyte/fluid disturbances, nasojejunal feeding). In the remaining patients, surgical or endocsopic therapy after radiologic characterisation of the fistula.
* not included in the 1992 Atlanta Classification. rate of infectious complications or mortality 125 . Similarly, a multicentre study including 100 patients with SAP did not observe a difference between prophylactic meropenem (1.0 g every eight hours) and placebo in terms of pancreatic or peripancreatic infection, requirement for surgical intervention or mortality 126 . Even though selective decontamination of the digestive tract was associated with a decrease in pancreatic infections and a mortality benefit among severely ill patients 127 , there is currently insufficient evidence to support its routine use.
Diagnosis of infected pancreatic necrosis
Clinical features that should alert the attending physician to pancreatic necrosis infection are persistent vasopressor dependency, prolonged MODS and new fever or any increase in inflammatory variables such as C-reactive protein or procalcitonin. Further symptoms may be confusion, hyperventilation, decreased urine output and/ or impaired peripheral circulation. Whenever one or more of these signs are present in patients with radiographic evidence of pancreatic necrosis, ultrasonography or computed tomography-guided fine needle aspiration of necrotic tissue with gram stain and culture is useful to discriminate between sterile and infected necrosis. Fine-needle aspiration should be directed at peripancreatic necrosis rather than intra-abdominal fluid collections 128 . The diagnostic sensitivity and specificity of bacterial cultures sampled by fine-needle aspiration to detect necrosis infection are 88% and 90% respectively 129 . Bleeding or exacerbation of pancreatic inflammation has been reported, but is very rare 7 .
Treatment of infected pancreatic necrosis
When infection of pancreatic necrosis is suspected and fine-needle aspiration is performed, it is prudent to start empiric antibiosis, particularly in patients with shock and MODS. After receipt of microbiological results antibiotics should be discontinued if the necrosis was sterile or adapted according to the antibiogram. Repeated fine-needle aspirations are recommended at five-to seven-day intervals if signs of infection persist 5 . When necrosis remains sterile, mortality is low: attempts to drain necrotic tissue only increase the risk of infection.
There is no evidence that antimicrobial therapy alone is adequate to treat infected pancreatic necrosis 8 . On the contrary, except for anecdotal reports 130 , conservative management of infected pancreatic necrosis was associated with 100% mortality 131 . There are several techniques for debridement and drainage of infected pancreatic necrosis. While open surgical necrosectomy is the traditional approach, various minimally invasive techniques have been introduced 7, 19 . The choice of technique strongly depends on the ratio of solid to semisolid components in the pancreatic necrosis. In the case of predominance of solid tissue, open techniques may be superior to minimally invasive approaches 132 . Surgery: Early surgical intervention has almost vanished from the management of SAP because of increased mortality rates 133 . Consequently, only few indications for surgery (e.g. abdominal compartment syndrome, intestinal ischaemia) remain during early acute pancreatitis. The aim of surgery in patients with infected pancreatic necrosis is to remove necrotic tissue and preserve as much vital tissue as possible 7 . Partial or total pancreatectomy should be avoided rigorously in order to reduce mortality and the risk of postoperative endocrine and exocrine pancreatic insufficiency 134, 135 . no consensus exists on the best surgical technique to debride pancreas necrosis. Most guidelines suggest three techniques which share comparable success and mortality rates: 1) open necrosectomy with closed continuous lavage of the retroperitoneum 136 ; 2) open necrosectomy combined either with planned re-laparotomies followed by delayed primary closure and drainage or with multiple drainage and re-laparotomy on demand 137 ; 3) open necrosectomy with open packing and planned re-laparotomies 138 .
Minimally invasive technique
Three minimally invasive techniques for debriding infected pancreatic necrosis have lately gained clinical acceptance. Whereas these techniques Guidelines summary statement: antibiotic prophylaxis Recommendations are controversial. Most guidelines do not recommend prophylactic antibiotics [4] [5] [6] 8 . Only the Japanese working group 9 and the International Association of Pancreatology 7 recommend antibiotic prophylaxis in SAP patients to reduce the rate of necrosis infection. All guidelines agree that antibiotic prophylaxis should not be given for >seven to 14 days.
Conflicting evidence:
There is an almost equal amount of data supporting or refuting the use of antibiotic prophylaxis in SAP. Only the results of a large multicentre trial may allow final recommendations to be made.
Guidelines summary statement: diagnosis of infected pancreas necrosis
All guidelines recommend fine-needle aspiration as the diagnostic method of choice to differentiate between sterile and infected pancreas necrosis.
were initially reserved for patients who were too sick to undergo surgical interventions, they have increasingly become used as first-line approaches. One method is minimally invasive retroperitoneal necrosectomy using a nephroscope 139, 140 . This is followed by high-volume lavage and placement of drains for continuous irrigation. Another technique is laparoscopic necrosectomy with placement of large-calibre drains under direct surgical inspection 141, 142 . The most encouraging results have been reported for the computed tomography-guided percutaneous catheter drainage technique [143] [144] [145] . However, close supervision, exchange or upsizing of irrigation catheters and placement of new catheters may frequently be required 5 .
Long-term outcome in SAP patients
In most survivors (~75%), health-related quality of life is good and comparable to that of the normal population 145, [147] [148] [149] [150] . However, other authors have suggested that, particularly in patients with a high disease severity, quality of life was reduced after the SAP episode 151 . In one study, >40% of SAP patients were found to have ongoing symptoms including abdominal pain and discomfort, diarrhoea, unintended weight loss and endocrine or exocrine pancreas insufficiency 152 . new onset diabetes mellitus was observed in 20 to 50% of patients after SAP 151, 153, 154 . The incidence of endocrine or exocrine pancreas insufficiency seems to be closely related to the extent of pancreas necrosis and surgical evacuation of pancreas parenchyma 7 . The incidence of chronic pancreatitis after an acute episode ranges between 3 and 13%. While cholecystectomy or sphincterotomy reduces the risk of recurrent episodes in biliary pancreatitis 155, 156 , almost half of patients with acute alcohol-associated pancreatitis experience recurrence of the disease 9 . During a median follow-up time of 61 months, 30% of survivors after alcohol-associated SAP were abstinent, 42% had a reduced alcohol intake, while 28% remained alcoholics 147 .
Guidelines summary statement: treatment of infected pancreatic necrosis
All guidelines agree that infected pancreatic necroses require debridement and drainage, while sterile necroses do not. Except for the Japanese guidelines, which prefer surgical necrosectomy 9 , all guidelines suggest either surgical or minimally invasive debridement and drainage, depending on individual patient features and locally available expertise.
Conflicting evidence:
Even though first experiences with minimally invasive techniques to treat abdominal infectious complications in SAP are encouraging, no adequately powered trial has so far compared these techniques to an open surgical approach. Furthermore, the value of individual minimally invasive techniques in the treatment of specific pancreatic pathologies (e.g. infected necrosis, abscess, pseudocyst) must be evaluated. The multicentre PAncreatitis, necrosectomy vs. sTEp up appRoach (PAnTER) is currently under way to compare surgical necrosectomy with a minimally invasive step-up approach (percutaneous drainage followed by videoscopeassisted retroperitoneal debridement if necessary) in SAP patient with necrosis infection 146 .
